دورية أكاديمية
The decline of malaria in Vietnam, 1991-2014.
| العنوان: | The decline of malaria in Vietnam, 1991-2014. |
|---|---|
| المؤلفون: | Goldlust SM; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam.; Department of Biology, Georgetown University, Washington, DC, USA.; Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA., Thuan PD; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam., Giang DDH; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam., Thang ND; National Institutes for Malariology, Parasitology, and Entomology, Hanoi, Vietnam., Thwaites GE; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Farrar J; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam.; The Wellcome Trust, London, UK., Thanh NV; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam., Nguyen TD; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam., Grenfell BT; Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA., Boni MF; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam. mfb9@psu.edu.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK. mfb9@psu.edu.; Center for Infectious Disease Dynamics, Department of Biology, Pennsylvania State University, University Park, PA, USA. mfb9@psu.edu., Hien TT; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK. |
| المصدر: | Malaria journal [Malar J] 2018 Jun 07; Vol. 17 (1), pp. 226. Date of Electronic Publication: 2018 Jun 07. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875 (Electronic) Linking ISSN: 14752875 NLM ISO Abbreviation: Malar J Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: London : BioMed Central, [2002- |
| مواضيع طبية MeSH: | Mosquito Control*, Antimalarials/*administration & dosage , Artemisinins/*administration & dosage , Malaria/*epidemiology , Malaria/*prevention & control , Plasmodium/*drug effects, Case Management ; Incidence ; Vietnam/epidemiology |
| مستخلص: | Background: Despite the well-documented clinical efficacy of artemisinin-based combination therapy (ACT) against malaria, the population-level effects of ACT have not been studied thoroughly until recently. An ideal case study for these population-level effects can be found in Vietnam's gradual adoption of artemisinin in the 1990s. Methods and Results: Analysis of Vietnam's national annual malaria reports (1991-2014) revealed that a 10% increase in artemisinin procurement corresponded to a 32.8% (95% CI 27.7-37.5%) decline in estimated malaria cases. There was no consistent national or regional effect of vector control on malaria. The association between urbanization and malaria was generally negative and sometimes statistically significant. Conclusions: The decline of malaria in Vietnam can largely be attributed to the adoption of artemisinin-based case management. Recent analyses from Africa showed that insecticide-treated nets had the greatest effect on lowering malaria prevalence, suggesting that the success of interventions is region-specific. Continuing malaria elimination efforts should focus on both vector control and increased access to ACT. |
| References: | Nature. 2015 Oct 8;526(7572):207-211. (PMID: 26375008) N Engl J Med. 2014 Jul 31;371(5):411-23. (PMID: 25075834) Evolution. 2013 Apr;67(4):1218-30. (PMID: 23550770) Trop Med Int Health. 2004 Jan;9(1):53-61. (PMID: 14728607) Adv Parasitol. 2002;52:235-64. (PMID: 12521262) PLoS Med. 2007 Nov 6;4(11):e309. (PMID: 17988171) J Infect Dis. 1994 Oct;170(4):971-7. (PMID: 7930743) PLoS Med. 2005 Apr;2(4):e92. (PMID: 15839740) Trans R Soc Trop Med Hyg. 1990 Jul-Aug;84(4):499-502. (PMID: 2091337) Expert Rev Anti Infect Ther. 2013 Jun;11(6):623-39. (PMID: 23750733) Lancet. 1993 Mar 6;341(8845):603-8. (PMID: 8094838) Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):210-1. (PMID: 1887472) Malar J. 2009 Feb 20;8:31. (PMID: 19228438) Malar J. 2008 Jul 09;7:125. (PMID: 18613962) Lancet. 2000 Jul 22;356(9226):297-302. (PMID: 11071185) Trans R Soc Trop Med Hyg. 1992 Nov-Dec;86(6):582-3. (PMID: 1287904) PLoS One. 2012;7(5):e37166. (PMID: 22662135) J Infect Dis. 2013 Jun 1;207(11):1637-45. (PMID: 23468056) PLoS Med. 2008 Nov 25;5(11):e226; discussion e226. (PMID: 19067479) Lancet. 2006 Jun 24;367(9528):2075-85. (PMID: 16798391) Antimicrob Agents Chemother. 1997 Jul;41(7):1413-22. (PMID: 9210658) Lancet. 1996 Jun 15;347(9016):1654-8. (PMID: 8642959) Trop Med Int Health. 2005 Mar;10(3):251-62. (PMID: 15730510) Trop Med Int Health. 2005 Apr;10(4):357-65. (PMID: 15807800) Malar J. 2015 Sep 30;14:381. (PMID: 26424000) Nat Commun. 2014 Nov 26;5:5606. (PMID: 25425081) Am J Trop Med Hyg. 2006 Aug;75(2 Suppl):32-7. (PMID: 16931813) Trans R Soc Trop Med Hyg. 2007 Mar;101(3):216-25. (PMID: 16979202) PLoS Med. 2005 Jul;2(7):e190. (PMID: 16033307) Malar J. 2015 Feb 19;14:86. (PMID: 25880664) Lancet. 2004 Jan 3;363(9402):18-22. (PMID: 14723988) Wellcome Open Res. 2017 Sep 6;2:81. (PMID: 29062913) Lancet Glob Health. 2015 Dec;3(12):e758-66. (PMID: 26545449) J Infect Dis. 2001 Apr 15;183(8):1254-9. (PMID: 11262208) Am J Trop Med Hyg. 2015 Apr;92(4):811-7. (PMID: 25667053) Nat Rev Microbiol. 2014 Dec;12(12):833-40. (PMID: 25329408) J Infect Dis. 2006 Apr 15;193(8):1151-9. (PMID: 16544256) Science. 2008 Apr 18;320(5874):330-4. (PMID: 18420924) Malar J. 2012 Oct 26;11:355. (PMID: 23101492) J Infect Dis. 2010 Feb 15;201(4):570-9. (PMID: 20085495) Malar J. 2016 Jul 15;15:363. (PMID: 27421656) Lancet. 2004 Jan 3;363(9402):9-17. (PMID: 14723987) Elife. 2015 Dec 29;4:null. (PMID: 26714109) Antimicrob Agents Chemother. 2017 Mar 24;61(4):. (PMID: 28137815) Lancet Infect Dis. 2017 May;17(5):491-497. (PMID: 28161569) Lancet Glob Health. 2017 Apr;5(4):e418-e427. (PMID: 28288746) Lancet Infect Dis. 2010 Aug;10(8):545-55. (PMID: 20637696) Clin Microbiol Rev. 2011 Apr;24(2):377-410. (PMID: 21482730) |
| معلومات مُعتمدة: | United Kingdom WT_ Wellcome Trust; P2C HD047879 United States HD NICHD NIH HHS; 098511/Z/12/Z United Kingdom WT_ Wellcome Trust; 089276/B/09/7 United Kingdom WT_ Wellcome Trust |
| فهرسة مساهمة: | Keywords: Artemisinin; Malaria; Urbanization; Vector control; Vietnam |
| المشرفين على المادة: | 0 (Antimalarials) 0 (Artemisinins) 9RMU91N5K2 (artemisinin) |
| تواريخ الأحداث: | Date Created: 20180609 Date Completed: 20190102 Latest Revision: 20210915 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC5992833 |
| DOI: | 10.1186/s12936-018-2372-8 |
| PMID: | 29880051 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1475-2875 |
|---|---|
| DOI: | 10.1186/s12936-018-2372-8 |